Pendapatan dodolan perusahaan aquestive.com (AQST)

Simbol lan logo merek aquestive.com (AQST)

Aquestive Therapeutics (AQST) sales levels on the GURU.Markets chart demonstrate revenue dynamics, where 0.05 characterizes this valuation parameter. Growth is driven by modern oral films that are displacing injections. The strategy is based on the implementation of PharmFilm to replace traditional auto-injectors for allergy treatment. The reputation of Aquestive Therapeutics (AQST) is built on creating convenient therapy formats that improve patient medication adherence.

Aquestive Pharma (AQST): Pendapatan perusahaan saka 04.07.2022 nganti 17.11.2026

Rincian metrik komprehensif lan analitis aquestive.com (AQST)

- rega pasar lan target rega analis:
Analisis komprehensif perusahaan:Aquestive Therapeutics
Barang utama Aquestive Therapeutics

For Aquestive Therapeutics (AQST), which is developing an express drug delivery system via soluble films, this indicator confirms the commercial demand for the new technology. The metric captures the actual daily cash inflow, separating real revenue from market noise. By analyzing the company's monthly sales, an investor can determine the stability of the cash flow and the business's stage of maturity. Growth in this figure indicates a patient shift toward the innovative standard of therapy, which confirms the fundamental resilience of the issuer's business model.

Perusahaan pesaing

HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Pendapatan perusahaan|AMRX - Pendapatan perusahaan|Total pendapatan perusahaan perrigo.com|ALVO (Alvotech SA) - Dodolan perusahaan|Total volume dodolan perusahaan Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Pendapatan lan volume dodolan|ANIP: Pendapatan dodolan perusahaan|Pendapatan perusahaan Afrezza (MNKD)|Pendapatan lan volume dodolan amphastar.com (AMPH)|Pendapatan lan volume dodolan PCRX (pacira.com)|Pendapatan dodolan perusahaan SPRY|Theravance Biopharma Inc - Pendapatan lan volume dodolan|scpharmaceuticals.com (SCPH) - Dodolan perusahaan|TECX: Pendapatan lan volume dodolan|Tonix Pharmaceuticals - Pendapatan dodolan perusahaan|Dodolan perusahaan SXTC|EPRX: Pendapatan dodolan perusahaan|Dodolan perusahaan BHST (BioHarvest Sciences Inc.)|Pendapatan reged perusahaan Invizyne|Pendapatan perusahaan Oramed Pharmaceuticals ORMP|Pendapatan dodolan perusahaan ENTX|HYFT - Pendapatan perusahaan|Pendapatan dodolan perusahaan ABVC (ABVC BioPharma Inc.)|CPIX: Pendapatan lan volume dodolan|Quantum BioPharma Limited - Pendapatan dodolan perusahaan|FGEN (FibroGen Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Telomir Pharmaceuticals|Pendapatan lan volume dodolan RANI|SNYR (Synergy CHC Corp.) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RLYB (Rallybio Corp)|LEXX: Volume dodolan perusahaan|PULM - Pendapatan perusahaan|PTHL: Pendapatan perusahaan|APM (aptorumgroup.com) - Dodolan perusahaan|Lyra Therapeutics - Pendapatan dodolan perusahaan|Pendapatan perusahaan Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan YCBD|PRFX: Pendapatan tahunan perusahaan|Pendapatan perusahaan altamiratherapeutics.com CYTO|Pendapatan lan volume dodolan Lipella Pharmaceuticals Inc LIPO|OPTN - Pendapatan perusahaan|Pendapatan reged perusahaan Pieris Pharma PIRS|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP